Murray Mandryk’s Jan 27 column entitled “Saskatchewan’s new drug ... letters to the editor. • Letters should be limited to no more than 250 words. • Include your full name, address ...

On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...

The trial involves the ex-president of the Spain football federation and one of the stars of the Spain women's team that won ...

Rashford got dropped for – checks note – ONE game. This bears repeating, a single game of football. What did he do? He ...

Putin's forces focus on attacking key eastern town of Pokrovsk amid heavy losses - Russian forces have captured hundreds of ...

Notably, on Oct. 4, 2024, John Rustad, leader of the Conservative Party of British Columbia, emphasized the urgent need for a second crossing over Okanagan Lake to address the region's growing ...

Authors can choose to publish the referee reports, editorial correspondence and decision letters alongside their paper – and ... The journals accept manuscripts and figures in any format or file type ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...